Lu-Ann Murdoch
ARTICLES BY THIS AUTHOR
- 9/15/2021
Safety of SSRI/SNRI antidepressants in pregnancy
Canadian Paediatric Society position statement reviews neonatal outcomes, infant monitoring and whether mothers using an SSRI/SNRI should breastfeed. - 9/13/2021
New Canadian public health guidance on using MMR vaccine in mumps outbreaks
Off-label administration of a third dose of measles-mumps-rubella vaccine in individuals previously vaccinated with two doses can be considered in mumps outbreaks. - 9/10/2021
Drug News—September 2021
A review of new launches, new indications, new dosage forms and Health Canada advisories - 9/9/2021
New brand of BCG now available in Canada for treatment of bladder cancer
Availability of Verity-BCG will help overcome years of intravesical BCG shortage, dose rationing and dose reductions. - 9/6/2021
Pfizer COVID-19 vaccine unlikely to cause relapse of Guillain-Barré syndrome
Study suggests minimal risk of relapse when Pfizer-BioNTech mRNA COVID-19 vaccine is given to patients with a history of GBS. - 9/1/2021
Ivermectin: efficacy and safety data lacking for COVID-19 prevention or treatment
Health Canada advises consumers not use veterinary or human dosage forms of ivermectin to prevent or treat COVID-19. - 8/30/2021
Six things to tell patients about the Delta variant of SARS-CoV-2
Spreads faster than early forms of SARS-CoV-2 and is now the predominant variant in Canada and the United States - 8/25/2021
2021 Canadian guidelines now available for management of asthma
Canadian Thoracic Society issues updated guidelines for the diagnosis and management of asthma in preschoolers, children and adults. - 8/23/2021
U.S. task force recommends screening for type 2 diabetes starting at age 35
Recommends screening for prediabetes and type 2 diabetes in overweight or obese adults who are 35 to 70 years of age. - 8/18/2021
Health Canada considering new oral antiviral for treatment of COVID-19
Merck’s molnupiravir is a twice-daily oral antiviral agent currently under study as a potential treatment for mild/moderate COVID-19.
